A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and ...

Neuropathy, a condition that affects individuals of all ages but is most common in older adults, often causes pain in the ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.